510(k) K212372
K212372 is an FDA 510(k) premarket notification submitted by Fitbit, Inc. for the device "Fitbit Irregular Rhythm Notifications". The FDA issued a decision of Substantially Equivalent on Apr 8, 2022. The device falls under product code QDB (Photoplethysmograph Analysis Software For Over-The-Counter Use), a Class II device regulated under 21 CFR 870.2790. Fitbit, Inc. has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 8, 2022
- Date Received
- Jul 30, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Photoplethysmograph Analysis Software For Over-The-Counter Use
- Device Class
- Class II
- Regulation Number
- 870.2790
- Review Panel
- CV
- Submission Type
- 510(k)
A photoplethysmograph analysis software device for over-the-counter use analyzes photoplethysmograph data and provides information for identifying irregular heart rhythms. This device is not intended to provide a diagnosis.
Need the full FDA record for Fitbit, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.